The Bacteriocin Company
OUR MISSION
To reduce the world's reliance on antibiotics and to introduce safe and sustainable alternatives to protect our food supply, and population, from disease.
About

Who we are

Nulla vel sodales tellus, quis condimentum enim. Nunc porttitor venenatis feugiat. Etiam quis faucibus erat, non accumsan leo. Aliquam erat volutpat. Vestibulum ac faucibus eros. Cras ullamcorper gravida tellus ut consequat.

Learn More
Team

What we do

Nulla vel sodales tellus, quis condimentum enim. Nunc porttitor venenatis feugiat. Etiam quis faucibus erat, non accumsan leo. Aliquam erat volutpat. Vestibulum ac faucibus eros. Cras ullamcorper gravida tellus ut consequat.

Learn More

Proteins for the post-antibiotic era.

Scientific breakthroughs happen every day.

Many of them never make it past the lab, as they aren't socially or economically feasible. Organicin is a venture-backed biotech company that has pioneered a proprietary bacteriocin discovery platform that overcomes major obstacles in antibacterial drug discovery; such as costs, efficacy & safety, resistance, and sustainability.

Our Mission

To reduce the world's reliance on antibiotics and to introduce safe and sustainable alternatives to protect our food supply, and population, from disease.

Our Technology

Computational drug discovery

Inspired by nature and perfected with science, Organicin Scientific uses proprietary machine learning algorithms to accelerate the discovery of novel bacteriocins.

Industry-agnostic

Working backwards from the problem, we discover bacteriocins that thrive in their specific application niche – whether that’s in aquaculture, agriculture, or human health.

Preventing disease and gut dysbiosis

Our discovery excellence has enabled us to develop a library of novel bacteriocins active against today's toughest animal health & food safety challenges, improving profits along the value chain.

What are bacteriocins?

Bacteriocins are not antibiotics. They are proteins produced by bacteria for the sole purpose of protecting their host against competing bacteria and are a powerful weapon in the fight against antibiotic resistance. Different from broad-spectrum antibiotics, they are highly targeted antimicrobials that inhibit growth of specific strains of bacteria, without harming the gut microbiome.

Our Team

Contact us

Have a question for us? Let us know & we will respond!

Fill out this form. Our support team will get back to you as soon as possible.

Thank you! We will get back in touch with you within 48 hours.
Oops! Something went wrong while submitting the form.

Press

BlueSwell Cohort Seeks Help Shaping Businesses

About four months ago, the second BlueSwell cohort gathered together at a networking event in Cambridge

Read More

Bluetech of the future: Who would you invest in?

This incubator was created by SeaAhead Inc. and the New England Aquarium in 2020 to bring bluetech innovations out of the lab and onto a path toward commercialization. BlueSwell

Read More

Bacteriocin-based functional feed additive to support sustainable aquaculture

read more

Top 15 start-ups chosen for 2022 Nutreco Feed & Food Tech Challenge

read more

Eight Startups Pursuing A Sustainable Blue Economy Via BlueSwell

read more

BlueSwell Cohort Seeks Help Shaping Businesses

read more

Bluetech of the future: Who would you invest in?

read more